Searched for
ANTI EPILEPTIC DRUG
True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Cipla to distribute Sanofi's CNS product line in IndiaAccording to the joint statement, Cipla will utilise its skills and solid India-wide network of distributors, institutions and market outre...
- Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medicationZydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat pa...
- Glenmark Pharma launches anti-epileptic drug, Rufinamide, in the USThe newly launched drug is a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc. Banzel tablets are used in combinat...
- Sun Pharma to launch complete range of generic anti-epilepsy drugThe drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solut...
- Some drugs more essential, govt moves to ensure supplyThe government has identified 55 drugs that hospitals in India need to manage coronavirus patients in intensive care units.
- Dr Reddy's launches generic oral anti-epileptic drug in USThe product is a generic version of Lundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing to the BSE.
- Good news for epileptic patients: Implanting new device in brain can prevent seizuresThe researchers used a neurotransmitter which acts as the 'brake' at the source.
- Planned pregnancy can help 90% epileptic women have healthy babiesNew Delhi, Nov 19 (IANS) Planned pregnancy can help 90 per cent of epileptic women deliver healthy babies, said doctors.
- SPARC, Sun Pharma slide as USFDA rescinds approval to drugShares of Sun Pharma Advanced Research Company today fell by almost 3 per cent as the US health regulator has revoked its earlier approval ...
- Aurobindo Pharma gets USFDA final nod for generic anti-epileptic drugAurobindo Pharma has received final nod from the US health regulator to make and market generic anti-epileptic Phenytoin Sodium capsules in...
- Sun Pharma recalls 3,263 bottles of epilepsy drug in USAs per the information available, Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing "dissolution spe...
- Glenmark gets USFDA nod for anti-epileptic drugGlenmark Pharmaceuticals today said its US-based arm has received approval from the US health regulator to market generic Lamictal tablets.
- Orchid receives USFDA nod for anti-epileptic tabletsOrchid Chemicals & Pharmaceuticals said it has received US FDA's approval to sell anti-epileptic levetiracetam tablets in the American mark...
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
- Glenmark gets tentative FDA nod for TopiramteGlenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.
- Zydus receives tentative approval for Topiramate tabletsCadila Healthcare today said it has received tentative USFDA approval for Topiramate Tablets, an anti-epileptic drug in multiple strengths.
- Alembic signs licensing agreement with UCBAlembic today said it has signed $11 million licensing agreement with Belgium-based UCB for anti-epileptic drug Keppra.
- Wockhardt gets nod for new drugWockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
Load More
